Skip to Main Content

Advertisement

Skip Nav Destination

Issue Archive

Table of Contents

BLOOD COMMENTARIES

PLENARY PAPER

Although genetic analysis is beginning to be incorporated into the assessment of myelodysplastic syndromes, the backbone of diagnosis remains assessment of bone marrow morphology. In this Plenary Paper, the authors describe the use of a machine-learning technique to integrate morphology with genomic events to develop distinct profiles with unique clinical profiles and prognosis.

PERSPECTIVE

In a Perspective, Venturutti and Melnick propose a novel origin for activated B-cell–type diffuse large B-cell lymphomas (ABC-DLBCLs). They present evidence that ABC-DLBCLs arise from aberrant memory B cells that carry founder mutations that block plasmacytic maturation and, under the influence of recurrent antigen exposure, undergo cyclical reactivation that facilitates both extranodal localization and progressive transformation.

REVIEW ARTICLE

Nucleoporin 98 (NUP98) rearrangements are seen in many hematologic malignancies, especially in poor-risk pediatric leukemia. In this definitive review, the authors discuss the role of NUP98 fusion proteins in transcriptional regulation, their cooccurrence with additional mutations, and prospects for exploiting experimental systems to identify therapeutic entry points for improved treatment of these poor-prognosis malignancies.

CLINICAL TRIALS AND OBSERVATIONS

The authors report on the outcome of convalescent plasma infusion in 17 patients with persistent COVID-19 in the setting of rituximab-induced severe B-cell depletion. All but 1 patient had clinical improvement accompanied by clearance of the virus.

HEMATOPOIESIS AND STEM CELLS

In a technical tour de force, the authors delineate the localization of hematopoietic stem cells (HSCs) within the bone marrow microenvironment through extensive examination of bone sections from HSC reporter lines. They elucidate the exact localization of HSCs and their association with heterogeneous niches within the marrow microenvironment.

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

Monoclonal antibodies targeting CD38 are effective therapy for multiple myeloma. The authors demonstrate that the expression of CD38 is modulated by the bone marrow microenvironment, with interleukin-6 downregulating CD38 expression through JAK-STAT3 signaling and decreasing the cytotoxic effect of daratumumab. JAK-STAT inhibition with ruxolitinib restores daratumumab sensitivity.

THROMBOSIS AND HEMOSTASIS

Babur et al performed extensive phosphoproteomic analysis of the signaling events in platelet activation mediated by GPVI, cataloguing the extensive signaling relations in this highly regulated network relevant to thrombosis and vascular inflammation.

BLOOD WORK

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X